Background: Several studies have shown that pulmonary telerehabilitation (PTR) improves respiratory capacity. However, there is little evidence of its effectiveness in youth with post-COVID-19 conditions (PCC). This study analyzed the effects of a PTR program on young adults with PCC.

Methods: Sixteen youths were randomly assigned to a control group (CG) or an experimental group (EG), with eight participants each. The EG participated in a PTR program that included twelve remote, asynchronous four-week sessions with diaphragmatic breathing and aerobic exercises. Vital signs (SpO, HR, RR, BP), physical capacity (sit-to-stand test), cardiorespiratory capacity (6-Minute Walk Test), and perceived exertion (Borg scale) were assessed in both groups.

Results: Statistical analyses showed a significant decrease in RR and HR ( < 0.012) and an increase in SpO ( < 0.042), physical ( < 0.012), and respiratory ( < 0.028) capacity. Perceived effort decreased significantly in both groups (CG: < 0.006; EG: < 0.001) only for physical but not for cardiorespiratory capacity ( < 0.106). There were no statistical changes registered in BP ( > 0.05).

Conclusions: The PTR program, which includes respiratory and aerobic exercises, is feasible and effective in improving physical and cardiorespiratory capacity in young people with PCC, as well as reducing HR, RR, and dyspnea.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11431331PMC
http://dx.doi.org/10.3390/healthcare12181864DOI Listing

Publication Analysis

Top Keywords

ptr program
12
cardiorespiratory capacity
12
pulmonary telerehabilitation
8
program young
8
young adults
8
post-covid-19 conditions
8
aerobic exercises
8
physical cardiorespiratory
8
capacity
6
implementing pulmonary
4

Similar Publications

Digital financial inclusion (DFI) has been proven to be a central factor in driving economic development and reducing inequality in countries. However, its impact on financial crises (FC) has yet to be clearly examined, particularly in the context of current Financial Development (FD). Therefore, this study examines the influence of DFI on FC across 52 countries from 2004 to 2020, focusing on how this impact varies with the level of FD.

View Article and Find Full Text PDF

Introduction: Chronic obstructive pulmonary disease (COPD) costs EURO 1.4 billion annually in healthcare costs. Pulmonary rehabilitation (PR) is a vital aspect of care for patients with COPD, but despite the compelling evidence, it is delivered to less than 30%.

View Article and Find Full Text PDF

Ischemic heart disease (IHD) impacts the quality of life and is the most frequently reported cause of morbidity and mortality globally. To assess the changes in the exhaled volatile organic compounds (VOCs) in patients with vs. without ischemic heart disease (IHD) confirmed by stress computed tomography myocardial perfusion (CTP) imaging.

View Article and Find Full Text PDF

The rising prevalence of multidrug-resistant (MDR) Gram-positive bacteria threatens the effectiveness of current antibiotic therapies. However, the development of new antibiotics has stagnated in recent years, highlighted the critical need for the discovery of innovative antimicrobial agents. This study aims to evaluate the antibacterial activity of naphthoquinones derived from Arnebia euchroma (Royle) Johnst (ADNs) and elucidate their underlying mechanisms.

View Article and Find Full Text PDF

Hypoglycemic Effect of Ginsenoside Compound K Mediated by N-Acetylserotonin Derived From Gut Microbiota.

Phytother Res

January 2025

Engineering Research Center of Applied Technology of Pharmacogenomics (Ministry of Education, China), Hunan Key Laboratory of Pharmacomicrobiomics, Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.

Article Synopsis
  • Ginsenoside compound K (GCK) has a significant hypoglycemic effect related to gut microbiota, but its precise mechanisms, especially in high-fat-diet-induced type 2 diabetes (T2D), are not well understood.
  • The study involved creating a diabetic mouse model and conducting fecal microbiota transplantation to explore GCK's role in regulating blood sugar levels.
  • Results indicated that GCK improved metabolic disorders and changed gut microbiota, leading to increased levels of N-acetylserotonin (NAS) and glucagon-like peptide-1 (GLP-1), thereby enhancing insulin sensitivity in the diabetic mice.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!